Cite
MLA Citation
Marta Castroviejo‐Bermejo et al.. “A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.” EMBO molecular medicine, vol. 10, no. 12, 2018, p. n/a. http://access.bl.uk/ark:/81055/vdc_100101398835.0x000019